Alzheimer's Disease Screening in Skilled Nursing Facilities
GIA® conducts screening conversations at the bedside, in the activity room, or by landline from the resident’s room — fitting naturally into existing daily routines without adding to nursing workload.
Why Alzheimer's Disease goes undetected in skilled nursing facilities
Licensed nurses manage 15-30 residents per shift. CNAs handle direct care for 8-12 residents. Time for proactive screening is virtually nonexistent. Alzheimer's Disease symptoms are often subtle, progressive, and easily attributed to other factors in this care environment.
CMS Five-Star ratings directly tied to clinical outcomes and survey results
MDS assessments require documented screening for cognitive and behavioral conditions
Staffing ratios make proactive screening nearly impossible during shifts
F-Tag deficiencies for missed conditions carry financial and reputational consequences
How does GIA® screen for Alzheimer's Disease in skilled nursing facilities?
GIA® meets the patient by video, voice, or landline — wherever they are in the skilled nursing facilitie environment. The screening conversation takes under five minutes and feels like a natural check-in, not a clinical assessment.
During the conversation, GIA® analyzes over 2,500 speech biomarkers — including vocal tremor, articulatory precision, prosodic patterns, and cognitive load indicators — alongside 436 visual data points from facial micro-expressions and body movement during video sessions.
Results are delivered to the clinician in 60 seconds. Four data types write back to the EHR automatically: structured screening results with ICD-10 codes, clinician-ready medical notes, a full timestamped transcript, and the recorded patient video. The clinician reviews and submits — the human is always in the loop.
What compliance requirements does this address?
MDS 3.0 Section C (Cognitive Patterns) and Section D (Mood) require documented screening. CMS F-Tag 758 requires psychotropic medication monitoring.
GIA® produces survey-ready documentation automatically — structured screening results, medical notes, full transcripts, and patient video — all written back to the EHR in real time. When a surveyor asks how you screen for alzheimer's disease, the answer is in the patient record: timestamped, structured, and reviewable.
Alzheimer's Disease screening in skilled nursing facilities
How is Alzheimer's Disease screened in skilled nursing facilities?
GIA® screens for Alzheimer's Disease through a single conversational interaction lasting under 5 minutes. She analyzes over 2,500 speech biomarkers using Voice AI, Computer Vision, and Speech Biomarkers. GIA® conducts screening conversations at the bedside, in the activity room, or by landline from the resident’s room — fitting naturally into existing daily routines without adding to nursing workload. Results are delivered to the clinician in 60 seconds.
Does Alzheimer's Disease screening require additional staff?
No. GIA® conducts the screening conversation independently — zero additional clinical staff required during the interaction. Licensed nurses manage 15-30 residents per shift. CNAs handle direct care for 8-12 residents. Time for proactive screening is virtually nonexistent. The clinician reviews the results in under 2 minutes.
What is the accuracy of Alzheimer's Disease screening?
Alzheimer's Disease screening accuracy: Clinically validated vocal biomarker screening. The platform is 510(k) registered and trained on 12.3 million longitudinal PAC/LTC patient records and 27 billion clinical events.
Alzheimer's Disease screening in other care settings
Other conditions screened in skilled nursing facilities
See GIA® screen for Alzheimer's Disease live
Under 5 minutes. 60-second results. Zero staff time.